Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection

Transplant Proc. 1997 Feb-Mar;29(1-2):609-11. doi: 10.1016/s0041-1345(96)00323-5.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Biopsy, Needle
  • Female
  • Follow-Up Studies
  • Graft Rejection / pathology
  • Graft Rejection / therapy*
  • Heart Transplantation* / immunology
  • Heart Transplantation* / pathology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Methotrexate / therapeutic use
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Photopheresis*
  • Recurrence
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Methylprednisolone
  • Methotrexate